Drug Shortage Report for PMS-PROGESTERONE
Report ID | 149248 |
Drug Identification Number | 02480247 |
Brand name | PMS-PROGESTERONE |
Common or Proper name | PROGESTERONE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | PROGESTERONE |
Strength(s) | 200MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-14 |
Estimated end date | 2022-06-13 |
Actual end date | 2022-07-22 |
Shortage status | Resolved |
Updated date | 2022-07-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-07-25 | French | Compare |
v3 | 2022-07-25 | English | Compare |
v2 | 2021-11-15 | French | Compare |
v1 | 2021-11-15 | English | Compare |
Showing 1 to 4 of 4